Astellas Pharma Inc. - Operating Income

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Operating-Income" stands at 344.14 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Astellas Pharma Inc.'s second quarter result of 107.64 Billion JPY for the item "Operating Income" represents an increase of 13.73 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 107.64 Billion JPY for the item "Operating Income" represents an increase of 77.84 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 344.14 Billion JPY for the item "Operating Income" represents an increase of 15.86 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 79.91 percent compared to the value the year prior.
The 1 year change in percent is 79.91.
The 3 year change in percent is 85.61.
The 5 year change in percent is 104.03.
The 10 year change in percent is 59.98.

The Serie's long term average value is 187.97 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 83.08 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +710.19%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.